Reference : Peut-on sortir de l'embrouillamini relatif aux contraceptifs oraux et aux cancers cutanés?
Scientific journals : Article
Human health sciences : Dermatology
http://hdl.handle.net/2268/8030
Peut-on sortir de l'embrouillamini relatif aux contraceptifs oraux et aux cancers cutanés?
French
[en] Can we sort out from the jumble about oral contraceptives and skin cancers?
Pierard, Gérald mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Pierard, Claudine [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Quatresooz, Pascale mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Kridelka, Frédéric mailto [Centre Hospitalier Universitaire de Liège - CHU > > Gynécologie-Obstétrique >]
Gaspard, Ulysse mailto [Centre Hospitalier Universitaire de Liège - CHU > > Gynécologie-Obstétrique >]
2007
Revue Médicale de Liège
62
5-6
463-6
Yes (verified by ORBi)
National
0370-629X
Belgium
[en] Contraceptives, Oral/adverse effects ; Female ; Humans ; Melanoma/chemically induced ; Skin Neoplasms/chemically induced
[en] Skin contains various hormonal receptors, particularly those for estrogens, progesterone and androgens. Steroid hormones of oral contraceptives affect the skin, in particular the control of the cell cycle, DNA replication, apoptosis and other cellular functions. Some estrogen-responsive pathways have the potential to promote tumor development. The question of whether oral contraceptives increase the risk for the development of skin cancer, particularly melanoma, remains an area of concern. There is some evidence that steroid hormones present in oral contraceptives do not significantly increase the risk of developing skin cancer when estrogen exposure is not excessive.
http://hdl.handle.net/2268/8030

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
CONTRACEPTIFS.pdfNo commentaryPublisher postprint245.42 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.